Key statistics
As of last trade Sangamo Therapeutics Inc (0R1D:LSE) traded at 0.9483, -37.61% below its 52-week high of 1.52, set on Feb 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 0.9483 |
Low | 0.9483 |
Bid | -- |
Offer | -- |
Previous close | 0.8712 |
Average volume | 66.76k |
---|---|
Shares outstanding | 208.22m |
Free float | 203.47m |
P/E (TTM) | -- |
Market cap | 199.93m USD |
EPS (TTM) | -1.38 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 14:41 BST.
More ▼
Press releases
- Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2024 Financial Results
- Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases
- Sangamo Therapeutics Reports on Pfizer’s Announcement of Positive Topline Results From Phase 3 Trial of Hemophilia A Gene Therapy Candidate